Pleryon Therapeutics develops polymer-based therapeutics targeting age-related medical conditions, focusing on applications in ophthalmology, orthopedics, and tissue regeneration. The company aims to meet significant unmet medical needs by advancing its preclinical pipeline with a funding base of nearly RMB 100 million from leading biotech investors.
Funding
$15.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many age-related medical conditions, such as those affecting the eyes, joints, and tissues, lack effective treatments that address the underlying causes of degeneration and promote regeneration. Current therapies often manage symptoms without fully restoring function or preventing disease progression.
Solution
Pleryon Therapeutics is developing a pipeline of polymer-based therapeutics designed to target the root causes of age-related diseases and promote tissue regeneration. Their approach utilizes advanced polymer chemistry to create novel therapies for ophthalmology, orthopedics, and other areas with significant unmet medical needs. By engineering polymers with specific properties, Pleryon aims to develop treatments that can restore tissue function, reduce inflammation, and slow down the aging process at a cellular level. These therapeutics are designed to be more effective and longer-lasting than existing options, offering patients improved quality of life.
Target Audience
The primary target audience includes patients suffering from age-related medical conditions, as well as physicians and healthcare providers seeking innovative treatment options.
Features
- Proprietary polymer platform for designing therapeutics with tailored properties
- Focus on ophthalmology, orthopedics, and tissue regeneration applications
- Preclinical pipeline of novel polymer-based therapies
- Targeted drug delivery to affected tissues
- Modulation of the inflammatory response
- Promotion of tissue regeneration and repair